Orange Book product · Generic (ANDA)
LITHIUM CARBONATE
LITHIUM CARBONATE
At a glance
Jun 10, 2015
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 10, 2015
11 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
LITHIUM CARBONATE
Strength
300MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 204445
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LITHIUM CARBONATE
- 1987LITHIUM CARBONATEBrand (NDA)
NDA 017812 · HIKMA
- 1985LITHANEBrand (NDA)
NDA 018833 · BAYER PHARMS
- 1982ESKALITH CRBrand (NDA)
NDA 018152 · JDS PHARMS
- 1982LITHIUM CARBONATEBrand (NDA)
NDA 018558 · HIKMA
- —ESKALITHBrand (NDA)
NDA 016860 · NOVEN THERAP
- —LITHONATEBrand (NDA)
NDA 016782 · SOLVAY
- —LITHOBIDBrand (NDA)
NDA 018027 · ANI PHARMS
- —ESKALITHBrand (NDA)
NDA 017971 · JDS PHARMS
- —LITHIUM CARBONATEBrand (NDA)
NDA 016834 · PFIZER
- —LITHOTABSBrand (NDA)
NDA 016980 · SOLVAY
- 2017LITHIUM CARBONATEGeneric (ANDA)
ANDA 205663 · UNIQUE
- 2016LITHIUM CARBONATEGeneric (ANDA)
ANDA 205532 · HERITAGE PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
